The FDA has placed a hold on all clinical studies of vaccines for respiratory syncytial virus in infants due to safety concerns following a trial involving two mRNA-based vaccine candidates from ...
Early results from Blue Lake trial found the vaccine to be safe, tolerated and able to cut the chance of contracting the infection.
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...
CIDRAP: Recombinant Pertussis Vaccine May Protect Teens For At Least 5 Years Researchers report that immunity against pertussis (whooping cough) was sustained 5 years after receipt of a ...
The burden of respiratory syncytial virus in young children continues to be high in the United States, according to study findings.
It’s that special time of year when family and friends come together to celebrate the holidays, share meals, spread cheer – ...
Exploring other people's motivations with empathy, respect and curiosity, instead of judgment, is at the core of effective ...
Symptoms of respiratory syncytial virus, or RSV, may start off similar to a common cold, with sneezing and a runny nose. But ...
RespiratorySyncytial Virus, or RSV, cases have been skyrocketing in Arkansas. The Arkansas Department of Health released new ...
A briefing document from the Food and Drug Administration (FDA) says that enrollment for all clinical studies of vaccines for ...
Bengaluru doctors are warning residents about a surge in respiratory and gastrointestinal infections attributed to ...
GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback